Brokerages expect that Wright Medical Group NV (NASDAQ:WMGI) will report $0.07 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Wright Medical Group’s earnings. Wright Medical Group posted earnings of $0.02 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 250%. The firm is scheduled to announce its next quarterly earnings report on Wednesday, August 5th.
According to Zacks, analysts expect that Wright Medical Group will report full year earnings of $0.42 per share for the current financial year, with EPS estimates ranging from $0.36 to $0.50. For the next fiscal year, analysts forecast that the company will report earnings of $0.63 per share. Zacks’ EPS calculations are a mean average based on a survey of analysts that that provide coverage for Wright Medical Group.
Wright Medical Group (NASDAQ:WMGI) last issued its quarterly earnings results on Friday, May 8th. The medical device company reported $0.03 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.08 by ($0.05). The company had revenue of $218.54 million during the quarter, compared to analyst estimates of $248.30 million. Wright Medical Group had a negative net margin of 16.57% and a negative return on equity of 5.67%.
Several equities analysts have issued reports on WMGI shares. TheStreet upgraded Wright Medical Group from a “d+” rating to a “c-” rating in a research report on Tuesday, July 14th. BidaskClub cut Wright Medical Group from a “sell” rating to a “strong sell” rating in a research report on Thursday, June 11th. Needham & Company LLC reiterated a “hold” rating on shares of Wright Medical Group in a research report on Wednesday. Finally, ValuEngine cut Wright Medical Group from a “buy” rating to a “hold” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $28.05.
In related news, insider Tim Lanier sold 2,299 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $29.39, for a total value of $67,567.61. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Kevin D. Cordell sold 4,860 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $29.61, for a total value of $143,904.60. The disclosure for this sale can be found here. In the last 90 days, insiders sold 9,594 shares of company stock worth $283,461. Insiders own 3.80% of the company’s stock.
Hedge funds have recently bought and sold shares of the stock. Sunbelt Securities Inc. purchased a new stake in Wright Medical Group in the 4th quarter valued at approximately $5,479,000. Advisor Group Holdings Inc. purchased a new position in shares of Wright Medical Group during the 1st quarter worth $33,000. Nisa Investment Advisors LLC lifted its stake in shares of Wright Medical Group by 299.4% during the 1st quarter. Nisa Investment Advisors LLC now owns 3,095 shares of the medical device company’s stock worth $89,000 after purchasing an additional 2,320 shares during the period. Signaturefd LLC lifted its stake in shares of Wright Medical Group by 53.8% during the 1st quarter. Signaturefd LLC now owns 8,009 shares of the medical device company’s stock worth $229,000 after purchasing an additional 2,803 shares during the period. Finally, Aigen Investment Management LP purchased a new position in shares of Wright Medical Group during the 1st quarter worth $349,000. 97.17% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ WMGI opened at $30.02 on Friday. The company has a current ratio of 0.82, a quick ratio of 0.56 and a debt-to-equity ratio of 0.90. The business’s 50 day moving average is $29.76 and its two-hundred day moving average is $29.47. Wright Medical Group has a 12-month low of $19.04 and a 12-month high of $30.66. The stock has a market capitalization of $3.87 billion, a price-to-earnings ratio of -40.57, a PEG ratio of 6.53 and a beta of 0.69.
Wright Medical Group Company Profile
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Featured Story: What is a bull market?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.